Table 5. Changes in the parameters of the oxidant-antioxidant system in blood plasma and urine according to the degree of their disturbances after basic treatment and inclusion of Viferon in acute pyelonephritis in different trimesters of pregnancy.

Research conditions

Altered laboratory values

Altered laboratory parameters, degree of impairment

absolute values

%

I

II

III

absolute values

%

absolute values

%

absolute values

%

Acute pyelonephritis in non-pregnant women

 15

93.8

4

25

3

18.8

8

50

Acute pyelonephritis in pregnant women, 1st trimester, before treatment

16

100

4

25

2

12.5

10

62.5

Acute pyelonephritis in pregnant women, 1st trimester, after basic treatment

11

68.8

3

18.8

4

25

4

25

Acute pyelonephritis in pregnant women, II trimester, before treatment

16

100

-

-

7

43.8

9

56.3

Acute pyelonephritis in pregnant women, II trimester, after basic treatment

15

93.8

1

6.3

5

31.3

10

62.5

Acute pyelonephritis in pregnant women, II trimester, after basic treatment and Viferon

11

68.8

2

12.5

3

18.8

6

37.5

Acute pyelonephritis in pregnant women, III trimester, before treatment

16

100

-

-

6

37.5

10

62.5

Acute pyelonephritis in pregnant women, III trimester, after basic treatment

13

81.3

3

18.8

1

6.3

10

62.5

Acute pyelonephritis in pregnant women, III trimester, after basic treatment and Viferon

11

68.8

3

18.8

2

12.5

6

37.5